Skip to Main Content

Paper Details

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).
J Immunother Cancer
32
2021
+ T cells, 3H-thymidine, B and T cell, CD137, CD4, CD4+, CD4+T, CD56bright, CD56bright NK cells, CD56bright natural killer (NK) cells, CD8, CD8+, CD8+T, CYT107, IFN, IFN-, IL-2, IL-7, IgG, IgM, PA2024, PAP, PSA, Recombinant human (rh) IL-7, T cell, human, interferon, interleukin (IL)-7, lymphocyte populations, lymphocyte subset, lymphocyte subsets, mCRPC, metastatic castration-resistant prostate cancer, patients, prostate specific antigen, prostatic acid phosphatase, rhIL-7, sip, sip-T
Author NameAffiliation
Russell K PachynskiWashington University School of Medicine
Holden T MaeckerInstitute for Immunity, Stanford University
Evan Y YuUniversity of Washington
Evan Y YuFred Hutchinson Cancer Research Center
Lawrence FongUniversity of California San Francisco
  • 1 - 5

Datasets

Release 1.2